Oncologie nieuws
- Secondary cytoreductive surgery and oncologic outcomes in the era of targeted maintenance therapy for recurrent, platinum-sensitive ovarian cancer
- Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin Lymphoma
- Molecular Genealogy of Metabolic-associated Hepatocellular Carcinoma
- Meta-analysis of the efficacy of neoadjuvant chemotherapy for locally advanced cervical cancer
- Phase II, Single-Arm Trial of Induction and Concurrent Vismodegib With Curative-Intent Radiation Therapy for Locally Advanced, Unresectable Basal Cell Carcinoma
- Adjuvant Alectinib Significantly Improves Disease-Free Survival in Patients with Resected ALK-positive Stage IB, II, or IIIA NSCLC
- <i>KRAS</i> G12 mutations as adverse prognostic factors in <i>KMT2A</i>-rearranged acute myeloid leukemia
- Mast cells and histamine in cholangiocarcinoma: exploring overlooked avenues for enhanced patient management
- Researchers discover urine-based test to detect head and neck cancer
- Parameter?based transfer learning for severity classification of atopic dermatitis using hyperspectral imaging
- Obinutuzumab interference with immunoelectrophoresis in a case of follicular lymphoma
- Erratum: Alcohol Intake and Risk of Lethal Prostate Cancer in the Health Professionals Follow-Up Study
- Global breast cancer report finds inequities persist
- TOPAZ─1 phase III trial shows AstraZeneca's Imfinzi plus chemotherapy doubled OS rate at three years for patients with advanced biliary tract cancer
- FGFR4-driven plasticity in breast cancer progression and resistance to therapy